Global Information
회사소개 | 문의 | 비교리스트

호흡기 진단 시장 : 세계 업계 동향, 점유율, 규모, 성장, 기회, 예측(2021-2026년)

Respiratory Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

리서치사 IMARC Services Private Limited
발행일 2021년 05월 상품코드 1007206
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 2,299 ₩ 3,265,000 PDF (Single User License)
US $ 3,399 ₩ 4,828,000 PDF (5 User License)
US $ 4,499 ₩ 6,391,000 PDF (Corporate License)


호흡기 진단 시장 : 세계 업계 동향, 점유율, 규모, 성장, 기회, 예측(2021-2026년) Respiratory Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
발행일 : 2021년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 호흡기 진단 시장 규모는 2015-2020년간 강력한 성장을 나타냈습니다. 2021-2026년간 세계의 호흡기 진단 시장은 약 7%의 CAGR로 성장할 것으로 예측됩니다. 호흡기 진단은 폐기능 및 관련 프로세스의 임상 평가를 가리킵니다. 여기에는 천식, 만성폐쇄성폐질환(COPD), 폐암, 기관지염 및 폐선유증을 검출하기 위한 기계적, 영상화 및 분자 진단 테스트가 몇 개 포함되고 있습니다. 폐활량측정법, 산소측정법, 경피 CO2 모니터링, 비흡기압(SNIP), 흉부 X선, 컴퓨터 단층촬영(CT) 스캔 등의 방법을 사용합니다. 경우에 따라서는 수면무호흡증 및 야간 저환기의 존재를 진단 및 평가하기 위해 수면 조사도 실시됩니다.

호흡기질환 유병률 상승은 시장 성장을 견인하는 중요한 요인의 하나입니다. 흡연자 증가와 음주 증가는 좌식 생활 습관이나 스트레스 많은 일과와 함께 COPD나 폐암 등의 기타 중증 호흡기질환 발생률을 높이고 있습니다. 또한 COPD 진단이나 외래 환자 관리를 위한 사물인터넷(IoT)이나 인공지능(AI) 이용 등 호흡기 진단 검사의 다양한 기술 혁신은 시장 성장에 플러스 영향을 주고 있습니다. 또한 다양한 개인 소유 병원이나 헬스케어 센터에서의 호흡 진단 장비 수요 증가 및 정부와 비정부 조직(NGO) 양방의 질 높은 헬스케어 시설을 모든 사람이 이용할 수 있도록 하는 대처가 호흡 진단 시장을 견인하고 있습니다. 시장 성장에 기여하는 기타 요인에는 연구개발(R&D) 강화, 고령자 인구 증가, 급속한 도시화와 산업시설 증가, 세계의 오염 레벨 상승 등이 있습니다.

세계의 호흡기 진단(Respiratory Diagnostics) 시장에 대해 조사했으며, 시장 개요와 함께 제품 및 서비스 종류별, 검사 종류별, 질환별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업 개요 등을 제공합니다.

목차

제1장 서문

제2장 범위와 조사 방법

제3장 주요 요약

제4장 서론

제5장 세계의 호흡기 진단 시장

  • 시장 개요
  • 시장 실적
  • COVID-19의 영향
  • 제품 및 서비스 종류별 시장 세분화
  • 검사 종류별 시장 세분화
  • 질환별 시장 세분화
  • 최종사용자별 시장 세분화
  • 지역별 시장 세분화

제6장 시장 세분화, 제품 및 서비스 종류별

  • 기기와 서비스
  • 어세이 및 시약
  • 서비스와 소프트웨어

제7장 시장 세분화, 검사 종류별

  • 기계 검사
  • 폐쇄성 수면무호흡증(OSA) 진단 검사
  • 영상 검사
  • 기존 진단 검사
  • 분자 진단 검사
  • 기타

제8장 시장 세분화, 질환별

  • 결핵
  • 천식
  • 만성폐쇄성폐질환(COPD)
  • 폐암
  • 기타

제9장 시장 세분화, 최종사용자별

  • 병원
  • 클리닉
  • 참조 및 임상 검사실
  • 기타

제10장 시장 세분화, 지역별

  • 북미
  • 유럽
  • 아시아태평양
  • 중동과 아프리카
  • 라틴아메리카

제11장 SWOT 분석

제12장 밸류체인 분석

제13장 Porter's Five Forces 분석

제14장 경쟁 상황

  • 시장 구조
  • 주요 기업
  • 주요 기업 개요
    • Philips Healthcare
    • Abbott Laboratories
    • Biomerieux
    • Becton Dickinson
    • Thermo Fisher Scientific Inc.
    • Alere Inc.
    • Seegene Inc.
    • 3M
    • Bio-Rad Laboratories Inc.
    • SDI Diagnostics
    • COSMED
KSM 21.06.09

List of Figures

  • Figure 1: Global: Respiratory Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Respiratory Diagnostics Market: Sales Value (in Billion US$), 2015 - 2020
  • Figure 3: Global: Respiratory Diagnostics Market: Breakup by Product and Service Type (in %), 2020
  • Figure 4: Global: Respiratory Diagnostics Market: Breakup by Test Type (in %), 2020
  • Figure 5: Global: Respiratory Diagnostics Market: Breakup by Disease (in %), 2020
  • Figure 6: Global: Respiratory Diagnostics Market: Breakup by End User (in %), 2020
  • Figure 7: Global: Respiratory Diagnostics Market: Breakup by Region (in %), 2020
  • Figure 8: Global: Respiratory Diagnostics Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 9: Global: Respiratory Diagnostics Industry: SWOT Analysis
  • Figure 10: Global: Respiratory Diagnostics Industry: Value Chain Analysis
  • Figure 11: Global: Respiratory Diagnostics Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Respiratory Diagnostics (Instruments and Services) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 13: Global: Respiratory Diagnostics (Instruments and Services) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 14: Global: Respiratory Diagnostics (Assays and Reagents) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 15: Global: Respiratory Diagnostics (Assays and Reagents) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 16: Global: Respiratory Diagnostics (Services and Software) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 17: Global: Respiratory Diagnostics (Services and Software) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 18: Global: Respiratory Diagnostics (Mechanical Tests) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 19: Global: Respiratory Diagnostics (Mechanical Tests) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 20: Global: Respiratory Diagnostics (Obstructive Sleep Apnoea Diagnostic Tests) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 21: Global: Respiratory Diagnostics (Obstructive Sleep Apnoea Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 22: Global: Respiratory Diagnostics (Imaging Tests) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Global: Respiratory Diagnostics (Imaging Tests) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 24: Global: Respiratory Diagnostics (Traditional Diagnostic Tests) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Global: Respiratory Diagnostics (Traditional Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 26: Global: Respiratory Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 27: Global: Respiratory Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 28: Global: Respiratory Diagnostics (Other Test Types) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 29: Global: Respiratory Diagnostics (Other Test Types) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 30: Global: Respiratory Diagnostics (Tuberculosis) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 31: Global: Respiratory Diagnostics (Tuberculosis) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 32: Global: Respiratory Diagnostics (Asthma) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 33: Global: Respiratory Diagnostics (Asthma) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 34: Global: Respiratory Diagnostics (Chronic Obstructive Pulmonary Disease) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 35: Global: Respiratory Diagnostics (Chronic Obstructive Pulmonary Disease) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 36: Global: Respiratory Diagnostics (Lung Cancer) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 37: Global: Respiratory Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 38: Global: Respiratory Diagnostics (Other Disease Types) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 39: Global: Respiratory Diagnostics (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: Global: Respiratory Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: Global: Respiratory Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: Global: Respiratory Diagnostics (Clinics) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: Global: Respiratory Diagnostics (Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 44: Global: Respiratory Diagnostics (Reference and Clinical Laboratories) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 45: Global: Respiratory Diagnostics (Reference and Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 46: Global: Respiratory Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 47: Global: Respiratory Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 48: North America: Respiratory Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 49: North America: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 50: Europe: Respiratory Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 51: Europe: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 52: Asia Pacific: Respiratory Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 53: Asia Pacific: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 54: Middle East and Africa: Respiratory Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 55: Middle East and Africa: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 56: Latin America: Respiratory Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 57: Latin America: Respiratory Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026

List of Tables

  • Table 1: Global: Respiratory Diagnostics Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Respiratory Diagnostics Market Forecast: Breakup by Product and Service Type (in Million US$), 2021-2026
  • Table 3: Global: Respiratory Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2021-2026
  • Table 4: Global: Respiratory Diagnostics Market Forecast: Breakup by Disease (in Million US$), 2021-2026
  • Table 5: Global: Respiratory Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2021-2026
  • Table 6: Global: Respiratory Diagnostics Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 7: Global: Respiratory Diagnostics Market Structure
  • Table 8: Global: Respiratory Diagnostics Market: Key Players

The global respiratory diagnostics market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Respiratory diagnostics refer to the clinical assessment of lung functioning and related processes. It includes several mechanical, imaging and molecular diagnostic tests for detecting asthma, chronic obstructive pulmonary disease (COPD), lung cancer, bronchitis, and pulmonary fibrosis. It uses procedures, such as spirometry, oximetry, transcutaneous CO2 monitoring, sniff nasal inspiratory pressure (SNIP), chest X-ray and computed tomography (CT) scan. In some instances, sleep studies are also conducted to diagnose and assess the presence of sleep apnea and nocturnal hypoventilation.

The growing prevalence of respiratory diseases is one of the key factors driving the growth of the market. The increasing number of smokers and consumption of alcohol, coupled with sedentary lifestyle habits and stressful routines, have resulted in rising incidences of COPD and other severe respiratory conditions, such as lung cancer. Furthermore, various technological innovations in respiratory diagnostic testing, including the utilization of Internet of Things (IoT) and Artificial Intelligence (AI) for the diagnosis of COPD and outpatient management, are creating a positive impact on the market growth. Also, an increase in the demand for respiratory diagnostics devices in various privately-owned hospitals and healthcare centers and efforts by both government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all are driving the market for respiratory diagnostics. Other factors contributing to the market growth include enhanced research and development (R&D), rising geriatric population, rapid urbanization and increasing industrial establishments, and growing pollution levels across the globe.

Report Coverage:

  • Historical, Current and Future Market Trends

Market Breakup by Product and Service Type:

  • Instruments and Services
  • Assays and Reagents
  • Services and Software

Market Breakup by Test Type:

  • Mechanical Tests
  • Obstructive Sleep Apnoea (OSA) Diagnostic Tests
  • Imaging Tests
  • Traditional Diagnostic Tests
  • Molecular Diagnostic Tests
  • Others

Market Breakup by Disease:

  • Tuberculosis
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Lung Cancer
  • Others

Market Breakup by End-User:

  • Hospitals
  • Clinics
  • Reference and Clinical Laboratories
  • Others

Market Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

  • The report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, Abbott Laboratories, Biomerieux, Becton Dickinson, Thermo Fisher Scientific, Alere Inc., Seegene Inc., 3M, Bio-Rad Laboratories, SDI Diagnostics, COSMED, etc.

Key Questions Answered in This Report:

  • How has the global respiratory diagnostics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global respiratory diagnostics industry?
  • What has been the impact of COVID-19 on the global respiratory diagnostics industry?
  • What is the breakup of the market based on the products and service type?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the disease?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the global respiratory diagnostics industry?
  • What are the key driving factors and challenges in the global respiratory diagnostics industry?
  • What is the structure of the global respiratory diagnostics industry and who are the key players?
  • What is the degree of competition in the global respiratory diagnostics industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Respiratory Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product and Service Type
  • 5.5 Market Breakup by Test Type
  • 5.6 Market Breakup by Disease
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product and Service Type

  • 6.1 Instruments and Services
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Assays and Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services and Software
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Mechanical Tests
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Obstructive Sleep Apnoea (OSA) Diagnostic Tests
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Imaging Tests
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Traditional Diagnostic Tests
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Molecular Diagnostic Tests
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Tuberculosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Asthma
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Chronic Obstructive Pulmonary Disease (COPD)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Lung Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Reference and Clinical Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Philips Healthcare
    • 14.3.2 Abbott Laboratories
    • 14.3.3 Biomerieux
    • 14.3.4 Becton Dickinson
    • 14.3.5 Thermo Fisher Scientific Inc.
    • 14.3.6 Alere Inc.
    • 14.3.7 Seegene Inc.
    • 14.3.8 3M
    • 14.3.9 Bio-Rad Laboratories Inc.
    • 14.3.10 SDI Diagnostics
    • 14.3.11 COSMED
Back to Top
전화 문의
F A Q